Pay in 4 interest-free payments of $5.48 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future
What are the benefits of Tirzepatide for weight loss
Topical application suits daily maintenance and localized skin concerns
This benefit persisted throughout the four-year study period, suggesting semaglutide does not just help you lose weight but actively protects your cardiovascular system
